I want to begin this piece by saying that I am eternally grateful for drugs. I might not be here today were it not for the amazing cancer drugs that have been developed. I also have a very clear idea of the cost of my treatment. For example, after each chemo I was given two injections for the next day, one for my red cells and one for my white cells. The amount that was on my billing was $9,000 each time for a total of $108,000 just for those shots.
The Preserve Access to Affordable Generics Act targets the practice of "pay to delay," and has been proposed by Senators Herb Kohl (D-WI) and Chuck Grassley (R-IA). In my humble opinion it has no chance in hell of being passed. Big Pharma has too firm a grip on our government. And if "pay to delay" concerns you then you should read no further.
So while I respect the pharmaceutical industry I also resent them for manipulating our healthcare for their own profit. "Oh no!", you say, "They're just trying to cover the cost of developing the drugs in the first place".
Let's assume that's true (it's not, but let's pretend). Do you know what else they have to cover the cost of? Consulting firms whose entire purpose is helping Big Pharma extend their patents through methods including litigation, filing "citizen petitions" and applying for "new indications".
There is a company out there (there are probably more, this is just the one I know about) called Cutting Edge Information who have published " Combating Generics; Counter- Genetics Strategy, Tactics and Execution" a 155 page white paper. This report can be yours for the low, low price of $3,295 with an extra $250 for a bound paper copy. That's 155 pages on how to keep people and insurance companies paying the full price of a brand name medication rather than a generic. And if you think that it's just a few companies you'd be wrong. Twenty six, from Abbott Laboratories to Wyeth, they're all there.
So the next time someone tells you we can't have health care for all, or how the Pharmaceutical industry "barely breaks even on new drugs", show them this and then feel free to tell them to shut up. Combating Generics: Counter-Generics Strategy, Tactics and Execution
The Preserve Access to Affordable Generics Act targets the practice of "pay to delay," and has been proposed by Senators Herb Kohl (D-WI) and Chuck Grassley (R-IA). In my humble opinion it has no chance in hell of being passed. Big Pharma has too firm a grip on our government. And if "pay to delay" concerns you then you should read no further.
So while I respect the pharmaceutical industry I also resent them for manipulating our healthcare for their own profit. "Oh no!", you say, "They're just trying to cover the cost of developing the drugs in the first place".
Let's assume that's true (it's not, but let's pretend). Do you know what else they have to cover the cost of? Consulting firms whose entire purpose is helping Big Pharma extend their patents through methods including litigation, filing "citizen petitions" and applying for "new indications".
There is a company out there (there are probably more, this is just the one I know about) called Cutting Edge Information who have published " Combating Generics; Counter- Genetics Strategy, Tactics and Execution" a 155 page white paper. This report can be yours for the low, low price of $3,295 with an extra $250 for a bound paper copy. That's 155 pages on how to keep people and insurance companies paying the full price of a brand name medication rather than a generic. And if you think that it's just a few companies you'd be wrong. Twenty six, from Abbott Laboratories to Wyeth, they're all there.
So the next time someone tells you we can't have health care for all, or how the Pharmaceutical industry "barely breaks even on new drugs", show them this and then feel free to tell them to shut up. Combating Generics: Counter-Generics Strategy, Tactics and Execution